These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 18023506

  • 1. Repeated novel cage exposure-induced improvement of early Alzheimer's-like cognitive and amyloid changes in TASTPM mice is unrelated to changes in brain endocannabinoids levels.
    Pardon MC, Sarmad S, Rattray I, Bates TE, Scullion GA, Marsden CA, Barrett DA, Lowe J, Kendall DA.
    Neurobiol Aging; 2009 Jul; 30(7):1099-113. PubMed ID: 18023506
    [Abstract] [Full Text] [Related]

  • 2. The occurrence of a deficit in contextual fear extinction in adult amyloid-over-expressing TASTPM mice is independent of the strength of conditioning but can be prevented by mild novel cage stress.
    Rattray I, Scullion GA, Soulby A, Kendall DA, Pardon MC.
    Behav Brain Res; 2009 Jun 08; 200(1):83-90. PubMed ID: 19162086
    [Abstract] [Full Text] [Related]

  • 3. Novel cage stress alters remote contextual fear extinction and regional T2 magnetic resonance relaxation times in TASTPM mice overexpressing amyloid.
    Rattray I, Pitiot A, Lowe J, Auer DP, Lima SJ, Schubert MI, Prior MJ, Marsden CA, Diaz FP, Kendall DA, Pardon MC.
    J Alzheimers Dis; 2010 Jun 08; 20(4):1049-68. PubMed ID: 20413887
    [Abstract] [Full Text] [Related]

  • 4. Powerful beneficial effects of benfotiamine on cognitive impairment and beta-amyloid deposition in amyloid precursor protein/presenilin-1 transgenic mice.
    Pan X, Gong N, Zhao J, Yu Z, Gu F, Chen J, Sun X, Zhao L, Yu M, Xu Z, Dong W, Qin Y, Fei G, Zhong C, Xu TL.
    Brain; 2010 May 08; 133(Pt 5):1342-51. PubMed ID: 20385653
    [Abstract] [Full Text] [Related]

  • 5. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
    Trinchese F, Liu S, Battaglia F, Walter S, Mathews PM, Arancio O.
    Ann Neurol; 2004 Jun 08; 55(6):801-14. PubMed ID: 15174014
    [Abstract] [Full Text] [Related]

  • 6. Cognitive correlates of Abeta deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes.
    Howlett DR, Richardson JC, Austin A, Parsons AA, Bate ST, Davies DC, Gonzalez MI.
    Brain Res; 2004 Aug 13; 1017(1-2):130-6. PubMed ID: 15261108
    [Abstract] [Full Text] [Related]

  • 7. Effects of progesterone administration and APPswe+PSEN1Deltae9 mutation for cognitive performance of mid-aged mice.
    Frye CA, Walf AA.
    Neurobiol Learn Mem; 2008 Jan 13; 89(1):17-26. PubMed ID: 17988898
    [Abstract] [Full Text] [Related]

  • 8. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
    Arendash GW, Schleif W, Rezai-Zadeh K, Jackson EK, Zacharia LC, Cracchiolo JR, Shippy D, Tan J.
    Neuroscience; 2006 Nov 03; 142(4):941-52. PubMed ID: 16938404
    [Abstract] [Full Text] [Related]

  • 9. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.
    Savonenko A, Xu GM, Melnikova T, Morton JL, Gonzales V, Wong MP, Price DL, Tang F, Markowska AL, Borchelt DR.
    Neurobiol Dis; 2005 Apr 03; 18(3):602-17. PubMed ID: 15755686
    [Abstract] [Full Text] [Related]

  • 10. Enrichment improves cognition in AD mice by amyloid-related and unrelated mechanisms.
    Costa DA, Cracchiolo JR, Bachstetter AD, Hughes TF, Bales KR, Paul SM, Mervis RF, Arendash GW, Potter H.
    Neurobiol Aging; 2007 Jun 03; 28(6):831-44. PubMed ID: 16730391
    [Abstract] [Full Text] [Related]

  • 11. Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern.
    Melnikova T, Savonenko A, Wang Q, Liang X, Hand T, Wu L, Kaufmann WE, Vehmas A, Andreasson KI.
    Neuroscience; 2006 Sep 01; 141(3):1149-62. PubMed ID: 16753269
    [Abstract] [Full Text] [Related]

  • 12. Corticotropin-releasing factor receptor 1 activation during exposure to novelty stress protects against Alzheimer's disease-like cognitive decline in AβPP/PS1 mice.
    Scullion GA, Hewitt KN, Pardon MC.
    J Alzheimers Dis; 2013 Sep 01; 34(3):781-93. PubMed ID: 23302658
    [Abstract] [Full Text] [Related]

  • 13. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice.
    Arendash GW, Jensen MT, Salem N, Hussein N, Cracchiolo J, Dickson A, Leighty R, Potter H.
    Neuroscience; 2007 Oct 26; 149(2):286-302. PubMed ID: 17904756
    [Abstract] [Full Text] [Related]

  • 14. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease.
    He J, Luo H, Yan B, Yu Y, Wang H, Wei Z, Zhang Y, Xu H, Tempier A, Li X, Li XM.
    Neurobiol Aging; 2009 Aug 26; 30(8):1205-16. PubMed ID: 18079026
    [Abstract] [Full Text] [Related]

  • 15. Reductions in endocannabinoid levels and enhanced coupling of cannabinoid receptors in the striatum are accompanied by cognitive impairments in the AβPPswe/PS1ΔE9 mouse model of Alzheimer's disease.
    Maroof N, Ravipati S, Pardon MC, Barrett DA, Kendall DA.
    J Alzheimers Dis; 2014 Aug 26; 42(1):227-45. PubMed ID: 24844690
    [Abstract] [Full Text] [Related]

  • 16. CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer's disease.
    Imbimbo BP, Giardino L, Sivilia S, Giuliani A, Gusciglio M, Pietrini V, Del Giudice E, D'Arrigo A, Leon A, Villetti G, Calzà L.
    J Alzheimers Dis; 2010 Aug 26; 20(1):159-73. PubMed ID: 20164581
    [Abstract] [Full Text] [Related]

  • 17. Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease mice.
    Arendash GW, Mori T, Cao C, Mamcarz M, Runfeldt M, Dickson A, Rezai-Zadeh K, Tane J, Citron BA, Lin X, Echeverria V, Potter H.
    J Alzheimers Dis; 2009 Aug 26; 17(3):661-80. PubMed ID: 19581722
    [Abstract] [Full Text] [Related]

  • 18. Physical exercise protects against Alzheimer's disease in 3xTg-AD mice.
    García-Mesa Y, López-Ramos JC, Giménez-Llort L, Revilla S, Guerra R, Gruart A, Laferla FM, Cristòfol R, Delgado-García JM, Sanfeliu C.
    J Alzheimers Dis; 2011 Aug 26; 24(3):421-54. PubMed ID: 21297257
    [Abstract] [Full Text] [Related]

  • 19. A detailed analysis of the early context extinction deficits seen in APPswe/PS1dE9 female mice and their relevance to preclinical Alzheimer's disease.
    Bonardi C, de Pulford F, Jennings D, Pardon MC.
    Behav Brain Res; 2011 Sep 12; 222(1):89-97. PubMed ID: 21440575
    [Abstract] [Full Text] [Related]

  • 20. Age-related decrease in stimulated glutamate release and vesicular glutamate transporters in APP/PS1 transgenic and wild-type mice.
    Minkeviciene R, Ihalainen J, Malm T, Matilainen O, Keksa-Goldsteine V, Goldsteins G, Iivonen H, Leguit N, Glennon J, Koistinaho J, Banerjee P, Tanila H.
    J Neurochem; 2008 May 12; 105(3):584-94. PubMed ID: 18042177
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.